Biggest prostate cancer screening trial in decades begins in UK
Summary
A major prostate cancer screening trial has started in the UK. The study aims to find better ways to detect the disease, focusing on combining MRI scans with blood tests. The trial involves men aged 50-74, with earlier invitations for black men starting at age 45 due to higher risk factors.Key Facts
- A prostate cancer screening trial called the Transform trial has begun in the UK.
- The trial is funded by Prostate Cancer UK and the National Institute for Health and Care Research.
- It involves men aged 50-74, with black men starting at age 45 because they are at a higher risk.
- The trial will test rapid MRI scans alongside PSA blood tests to improve diagnosis.
- PSA tests currently used can miss aggressive cancers or detect cancers that don't require treatment.
- Spit tests that analyze DNA from saliva will also be tested for accuracy.
- Initial results of the trial are expected in about two years and may involve up to 300,000 men.
- The trial aims to reduce the 12,000 early deaths from prostate cancer in the UK each year.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
